Daily non-political popular news in brief.

Drug/intervention combinations offer benefit in severe CVD

03-26-2007 · EurekAlert!

While millions of Americans suffer from severe cardiac dysfunction, only about 3,000 heart transplants are possible each year. In the meantime, doctors are trying to identify new combinations of medicines and interventions that will increase survival rates among this high-risk population. Research presented today at the American College of Cardiology's 56th Annual Scientific Session offers new insight into the most effective therapies for patients with severe left ventricular dysfunction, cardiogenic shock and perioperative hypertension.

Keywords: drug, intervention, combinations, offer, benefit, severe, cvd, combination

« Previous | Next »

Similar news on "Drug/intervention combinations offer benefit in severe CVD":

Researchers begin randomized double-blind trial of airway bypass treatment for emphysema
05-17-2007 · EurekAlert!
Broncus Technologies Inc., today announced the start of its EASE (Exhale Airway Stents for Emphysema) Trial to explore an investigational procedure that may offer a new, minimally-invasive treatment option for millions of emphysema sufferers. The study focuses on a procedure called airway bypass that uses drug-eluting stents to reinforce new pathways in the lung for trapped air to escape. This in turn, may relieve severe emphysema symptoms such as shortness of breath.
Similar news · Read more »
Is there a role for serial outpatient drug infusions in advanced heart failure?
03-25-2007 · EurekAlert!
For patients with severe chronic heart failure, known as stage D or chronic decompensated heart failure (CDHF), hospitalization is frequent and treatment options are limited. The FUSION II trial (Follow-Up Serial Infusions of Nesiritide in Advanced Heart Failure) tested the benefit of a novel drug infusion regimen of serial administration of nesiritide (NES) versus placebo in outpatients with advanced heart failure and a primary endpoint of all cause mortality and cardiorenal hospitalizations.
Similar news · Read more »
Studies highlight advances in diagnosis, medical therapy
03-26-2007 · EurekAlert!
Three studies being presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit 2007 highlight the breadth of research propelling advances in clinical cardiology. One study explores the best medical and interventional treatment for patients with acute coronary syndromes, the second demonstrates the long-lasting promise of non-surgical approaches to the repair of heart valves, and the third highlights a new drug-exercise combination that improves image quality and reduces side effects.
Similar news · Read more »
Drug-free treatments offer hope for older people in pain
09-10-2007 · EurekAlert!
Mind-body therapies, which focus on the interactions between the mind, body and behavior, and the ways in which emotional, mental, social and behavioral factors can affect health, may be of particular benefit to elderly chronic pain sufferers. A new study published in Pain Medicine provides a structured review of eight mind-body interventions for older people, including progressive muscle relaxation, meditation, hypnosis, tai chi and yoga.
Similar news · Read more »
Drug and procedural interventions offer better quality of life
03-26-2007 · EurekAlert!
Emergency and nonemergency care of cardiovascular disease have continually improved over the past decade, thanks to improved quality of care, novel procedures and better therapies. Research on improved care of cardiovascular disease shows improvements with a combination of drug and risk factor interventions. Three studies presented today at the American College of Cardiology's 56th Annual Scientific Session assess how continued improvements in cardiac care can lead to enhanced clinical practice and improved quality of life.
Similar news · Read more »
Drug combination might offer hope for patients deadly brain tumors
10-18-2007 · EurekAlert!
Brain cancer patients with the poorest prognosis -- those with a type of deadly tumor known as glioblastoma multiforme -- may survive longer with a drug that chokes off a tumor's blood supply.
Similar news · Read more »
Medication does not appear to offer benefit for certain heart attack patients undergoing PCI
01-02-2007 · EurekAlert!
Use of the drug pexelizumab immediately before and for 24 hours after stent placement or angioplasty for certain heart attack patients did not have any significant treatment effect compared to placebo, according to a study in the Jan. 3 issue of JAMA. The medication had shown promise in preliminary studies.
Similar news · Read more »
Discovery of good -- and bad -- liver stem cells raises possibility of new treatment
02-08-2008 · EurekAlert!
Many scientists believe up to 40 percent of liver cancer is caused by stem cells gone wild. Despite years spent looking, no one has ever found these liver "cancer stem cells." Now, researchers at Georgetown University Medical Center report discovering both types of stem cells, and by comparing their genetic "signatures," they found evidence to suggest that a new type of experimental drug might offer benefit in treating liver cancer.
Similar news · Read more »
New Engineered Drug May Offer Prolonged Arthritis Relief
10-14-2006 · ScienceDaily
Researchers at Duke University have devised a new way to significantly prolong the effects of an anti-inflammatory drug, potentially making it useful for providing longer-lasting treatment for osteoarthritis, the most common form of arthritis.
Similar news · Read more »
Researchers discover treatment for spinal cord injury pain
11-27-2006 · EurekAlert!
Spinal cord injury patients with moderate to severe nerve pain experienced less pain and in some cases no pain while taking the drug pregabalin, according to a study published in the Nov. 28, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology.
Similar news · Read more »